Guideline | Drug Name |
---|---|
Daraprim (pyrimethamine) | Daraprim (pyrimethamine) |
Darzalex (daratumumab), Darzalex Faspro (daratumumab and hyaluronidase-fihj) - PA, NF | Darzalex (daratumumab), Darzalex Faspro (daratumumab and hyaluronidase-fihj) |
DAW Override | DAW override, Dispense, written |
Deferasirox products | Exjade (deferasirox), deferasirox tablet, Jadenu (deferasirox), Jadenu Sprinkle (deferasirox) |
Demser (metyrosine) | Demser (metyrosine) |
Denosumab 120mg Products | Xgeva (denosumab), Wyost (Denosumab-bbdz), Osenvelt (denosumab-bmwo) |
Denosumab 60mg Products | Prolia (denosumab), Jubbonti (denosumab-bbdz), Stoboclo (denosumab-bmwo) |
Diabetic GLP-1's | Bydureon BCise (exenatide extended-release), Byetta (exenatide injection), Mounjaro (tirzepatide), Ozempic (semaglutide), Rybelsus (semaglutide), Trulicity (dulaglutide), Victoza (liraglutide injection) |
Diacomit (stiripentol) | Diacomit (stiripentol) |
Dibenzyline (phenoxybenzamine) | Dibenzyline (phenoxybenzamine) |
Dichlorphenamide Agents | Keveyis (dichlorphenamide), Ormalvi (dichlorphenamide) |
DPP-4 Inhibitors | Janumet (sitagliptin/metformin), Janumet XR (sitagliptin/metformin extended-release), Januvia (sitagliptin), Jentadueto (linagliptin/metformin), Jentadueto XR (linagliptin/metformin extended-release), Tradjenta (linagliptin) |
Duexis (ibuprofen and famotidine) | Duexis (ibuprofen/famotidine) |
Dupixent (dupilumab) | Dupixent (dupilumab) |
Ebglyss (lebrikizumab-lbkz) | Ebglyss (lebrikizumab-lbkz) |
Eculizumab Products | Bkemv (eculizumab-aeeb), Epysqli (eculizumab-aagh), Soliris (eculizumab) |
Elaprase (idursulfase) | Elaprase (idursulfase) [1] |
Elmiron (pentosan polysulfate sodium) | Elmiron (pentosan polysulfate sodium) |
Emflaza (deflazacort) - PA, NF | Emflaza (deflazacort) |
Enbrel (etanercept) | Enbrel (etanercept) |